FDA Approves First of New Drugs for Dry Eye

Image result for FDA Approves First of New Drugs for Dry Eye.  image

July 13, 2016 — The U.S. Food and Drug Administration on Tuesday gave the nod to the first of a new class of medications against  disease.

 (lifitegrast) eyedrops are a newly developed type of drug called LFA-1 agonists, the agency explained in a news release.

“Normal tear production is needed for clear vision and ,” Dr. Edward Cox, who directs the FDA’s Office of Antimicrobial Products, said in the news release. “This approval will provide a new treatment option for patients with  disease.”

Many older Americans experience dry eye disease, which the FDA says affects about 5 percent of adults in their 30s, and up to 15 percent of people over the age of 65.CONTINUE READING BELOW


The issue can become serious. “When severe and left untreated, this condition can lead to pain, ulcers or scars on the part of the eye called the ,” the FDA explained.

Xiidra’s safety and effectiveness was assessed in more than 1,000 adults in four separate . Patients received either Xiidra eyedrops or a  eyedrop twice daily for three months. According to the FDA, people taking Xiidra gained more improvement in “both the signs and the symptoms of  dryness” compared to those taking the placebo.

Side effects included  irritation, blurred  and “an unusual taste sensation,” the FDA said. Xiidra is made by Shire US, of Lexington, Mass.

Reference; http://your.healthycare247.com/fda-approves-first-of-new-drugs-for-dry-eye/

Leave a Reply

Your email address will not be published.